Is there a role for probiotics in the prevention or treatment of food allergy? (Q38128232)

29 August 2017

Is there a role for probiotics in the prevention or treatment of food allergy? (English)

1 reference

29 August 2017

0 references

3

Erika Isolauri

1 reference

29 August 2017

2

Seppo Salminen

1 reference

29 August 2017

Merja Nermes

1

1 reference

29 August 2017

1 December 2013

1 reference

Current Allergy and Asthma Reports

29 August 2017

1 reference

29 August 2017

13

1 reference

29 August 2017

6

1 reference

29 August 2017

622-630

1 reference

https://scigraph.springernature.com/pub.10.1007/s11882-013-0381-9

29 August 2017

0 references

cites work

Update on food allergy

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Microarray analysis reveals marked intestinal microbiota aberrancy in infants having eczema compared to healthy children in at-risk for atopic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

The link between the epidemics of obesity and allergic diseases: does obesity induce decreased immune tolerance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Determinants of systemic manifestations of food allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Immune responses to the microbiota at the intestinal mucosal surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Role of the gut microbiota in the development and function of lymphoid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

21 January 2018

Mechanisms of mitophagy

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Time trends in allergic disorders in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Obesity: What is an elderly population growing into?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Bifidobacterium and Lactobacillus DNA in the human placenta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Bacterial imprinting of the neonatal immune system: lessons from maternal cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Probiotics modulate host-microbe interaction in the placenta and fetal gut: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Host remodeling of the gut microbiome and metabolic changes during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Is meconium from healthy newborns actually sterile?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

New insights in gut microbiota establishment in healthy breast fed neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Development of bacterial and bifidobacterial communities in feces of newborn babies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Longitudinal investigation of the faecal microbiota of healthy full-term infants using fluorescence in situ hybridization and denaturing gradient gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Development of the human infant intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Sharing of bacterial strains between breast milk and infant feces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Dendritic cells and (CD4+)CD25+ T regulatory cells: crosstalk between two professionals in immunity versus tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Oral tolerance in the absence of naturally occurring Tregs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Oral tolerance to food-induced systemic anaphylaxis mediated by the C-type lectin SIGNR1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Gut-tropic T cells that express integrin α4β7 and CCR9 are required for induction of oral immune tolerance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Allergy development and the intestinal microflora during the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

The hygiene hypothesis of atopic disease--an extended version.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

The dynamics of gut-associated microbial communities during inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human- mucus binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Analysis of the genome sequence of Lactobacillus gasseri ATCC 33323 reveals the molecular basis of an autochthonous intestinal organism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Manufacturing process influences properties of probiotic bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Diagnostic approach and management of cow's-milk protein allergy in infants and children: ESPGHAN GI Committee practical guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Health claims in Europe: probiotics and prebiotics as case examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Recommendations for probiotic use-2011 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Duodenal infusion of donor feces for recurrent Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

The effects of selected probiotic strains on the development of eczema (the PandA study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Impact of maternal supplementation with probiotics during pregnancy on atopic eczema in childhood--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Probiotics during weaning reduce the incidence of eczema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Probiotics: a novel approach in the management of food allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Probiotics in the management of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Effect of probiotics on the treatment of children with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Lactobacillus salivarius plus fructo-oligosaccharide is superior to fructo-oligosaccharide alone for treating children with moderate to severe atopic dermatitis: a double-blind, randomized, clinical trial of efficacy and safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Effects of probiotics on atopic dermatitis: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Probiotics and allergy in children--an update review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Lactobacillus rhamnosus GG attenuates interferon-{gamma} and tumour necrosis factor-alpha-induced barrier dysfunction and pro-inflammatory signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Probiotic supplementation in the first 6 months of life in at risk Asian infants - effects on eczema and atopic sensitization at the age of 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Breast Milk: A Source of Bifidobacteria for Infant Gut Development and Maturation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Measurement of aggregation properties between probiotics and pathogens: In vitro evaluation of different methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0381-9

Is the effect of probiotics on atopic dermatitis confined to food sensitized children?

21 January 2018

1 reference

12 December 2020

The prevalence of food allergy: A meta-analysis

1 reference

12 December 2020

The impact of perinatal immune development on mucosal homeostasis and chronic inflammation

1 reference

12 December 2020

Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Probiotics and prebiotics: health claim substantiation

1 reference

12 December 2020

European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: executive summary

1 reference

12 December 2020

The relationship of breast-feeding, overweight, and asthma in preadolescents

1 reference

12 December 2020

Development of healthy gut microbiota early in life

1 reference

12 December 2020

Formula selection for management of children with cow's milk allergy influences the rate of acquisition of tolerance: a prospective multicenter study.

1 reference

12 December 2020

Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort

1 reference

12 December 2020

Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing

1 reference

12 December 2020

Effect of probiotic Lactobacillus strains in children with atopic dermatitis

1 reference

12 December 2020

Quality assurance criteria for probiotic bacteria

1 reference

12 December 2020

The rising incidence of paediatric-onset inflammatory bowel disease

1 reference

12 December 2020

Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study

1 reference

12 December 2020

Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial

1 reference

12 December 2020

Faecal microbiota and short-chain fatty acid levels in faeces from infants with cow's milk protein allergy

1 reference

12 December 2020

The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction

1 reference

12 December 2020

Breast milk-mediated transfer of an antigen induces tolerance and protection from allergic asthma

1 reference

12 December 2020

Probiotics and prebiotics: clinical effects in allergic disease

1 reference

12 December 2020

The acquisition of tolerance toward cow's milk through probiotic supplementation: a randomized, controlled trial

1 reference

12 December 2020

Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome

1 reference

12 December 2020

Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study

1 reference

12 December 2020

Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial

1 reference

12 December 2020

Resected human colonic tissue: new model for characterizing adhesion of lactic acid bacteria.

1 reference

12 December 2020

Specific probiotics in enhancing maturation of IgA responses in formula-fed infants

1 reference

12 December 2020

Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial

1 reference

12 December 2020

Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant

1 reference

12 December 2020

Assessment of bacterial diversity in breast milk using culture-dependent and culture-independent approaches

1 reference

12 December 2020

Probiotics reinforce mucosal degradation of antigens in rats: implications for therapeutic use of probiotics

1 reference

12 December 2020

Failure to induce oral tolerance to protein antigens in neonatal mice can be corrected by transfer of adult spleen cells

1 reference

12 December 2020

Food allergy: recent advances in pathophysiology and diagnosis

1 reference

12 December 2020

10.1007/S11882-013-0381-9

Identifiers

DOI

1 reference

PubMed ID

23934549

Dimensions Publication ID

29 August 2017

0 references

1 reference

PubMed ID

23934549